Stay updated on Recombinant Prourokinase for Acute Pulmonary Embolism Clinical Trial

Sign up to get notified when there's something new on the Recombinant Prourokinase for Acute Pulmonary Embolism Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Recombinant Prourokinase for Acute Pulmonary Embolism Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The funding/operating-status notice banner was removed. The study details, locations, and eligibility criteria remain unchanged.
    Difference
    0.3%
    Check dated 2025-11-17T17:22:35.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    No additions or deletions were detected on the page. The content appears unchanged between the two screenshots.
    Difference
    0.4%
    Check dated 2025-11-03T11:38:52.000Z thumbnail image
  4. Check
    43 days ago
    Change Detected
    Summary
    Updated the page to v3.2.0 with a prominent notice about potential data/tansaction delays due to funding gaps and where to check operating status; previous v3.1.0 reference removed.
    Difference
    5%
    Check dated 2025-10-05T17:19:35.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    Update: revision tag changed from v3.0.2 to v3.1.0; no substantive content changes detected.
    Difference
    0.1%
    Check dated 2025-09-28T10:09:25.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2 and the Back to Top element was removed; no other substantive changes to content, pricing, stock, or time slots.
    Difference
    0.3%
    Check dated 2025-09-14T00:22:10.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content or other important elements.
    Difference
    0.3%
    Check dated 2025-09-06T21:22:24.000Z thumbnail image

Stay in the know with updates to Recombinant Prourokinase for Acute Pulmonary Embolism Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Recombinant Prourokinase for Acute Pulmonary Embolism Clinical Trial page.